Dr. Gustavo Lara, MD

Dr. Lara practices at Nurick Surgical Institute Inc in Riverside, California.

Dr. Lara's NPI, 1639132392, was assigned on April 11, 2006. Dr. Lara graduated from Harvard Medical School in 1994. Dr. Lara holds California license A77165.

Dr. Lara's primary practice is Nurick Surgical Institute Inc, at 7111 Indiana Ave, Riverside, CA 92504 in Riverside County. The practice phone is (951) 276-9012.

Dr. Lara's primary practice is Nurick Surgical Institute Inc in Riverside, California. Dr. Lara is also affiliated with Riverside Community Hospital. The medical group on file is Nurick Surgical Institute. Dmand AI also links Dr. Lara to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lara practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Lara's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Lara is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Lara's licenses on file in 2 states: California and Texas.

Dmand AI lists abdominal hernia repair surgery, amputation, blood vessel access for dialysis, colon removal, gallbladder removal, gastrointestinal bleeding, groin hernia surgery and removal of damaged skin or skin graft among the conditions Dr. Lara treats.

CMS data shows 290 Medicare services from Dr. Lara across 4 procedure codes in 2024, for 161 Medicare patients. Medicare paid $27,362 for them.

CMS counts 161 Medicare patients who saw Dr. Lara in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 4.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lara's median patient age at 60, with 53% women.

In 2024, Dr. Lara wrote 147 Medicare Part D claims for 118 patients. 96% of them were for generic drugs. CMS names the drug for 126 of them, across 3 drugs with 11 or more claims each, at $305 in total drug cost. In 2023, CMS named 97 claims across 2 drugs.

Dr. Lara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of removal of tissue by Dr. Lara, more than 65% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Lara, published from 2019 to 2021. 2019 was the busiest year, with 2. The most frequent topics are Blood Vessel Prosthesis Implantation and Endovascular Procedures. Dr. Lara has published most often in Ann Vasc Surg. Dr. Lara's most frequent co-authors are Iden David Andacheh, MD, Harvey A. Nurick, MD and Mohamed A. Ahmed, MD.

CMS Open Payments shows 68 general payments to Dr. Lara from 22 drug and device companies from 2016 to 2025. Education make up the largest share, 58% of the total. Intuitive Surgical, Inc. paid the most, $12,934.

Dmand AI lists 2 awards for Dr. Lara, most recently CMS Stage 1 EHR in 2013.

Dr. Lara graduated from Harvard Medical School in 1994. Dr. Lara is a member of ACS.

Dr. Lara is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.